We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
60 hedge funds and large institutions have $105M invested in Verrica Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.12% less ownership
Funds ownership: 4.31% → 4.18% (-0.12%)
6% less funds holding
Funds holding: 64 → 60 (-4)
21% less capital invested
Capital invested by funds: $133M → $105M (-$27.5M)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
57% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 21
70% less call options, than puts
Call options by funds: $9K | Put options by funds: $30K
Holders
60
Holders Change
-4
Holders Change %
-6.25%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
21
Closed
10
Calls
$9K
Puts
$30K
Net Calls
-$21K
Net Calls Change
+$390K
Top Buyers
Top Sellers
| 1 |
MML Investors Services
Springfield,
Massachusetts
|
-$664K |
| 2 |
Morgan Stanley
New York
|
-$488K |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$478K |
| 4 |
JGC
J. Goldman & Co
New York
|
-$447K |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$351K |
